| Literature DB >> 27104578 |
Rebeca Miranda-Castro1, Noemí de-los-Santos-Álvarez2, Arturo J Miranda-Ordieres3, María Jesús Lobo-Castañón4.
Abstract
Celiac disease is a lifelong autoimmune disorder triggered by foods containing gluten, the storage protein in wheat, rye, and barley. The rapidly escalating number of patients diagnosed with this disease poses a great challenge to both food industry and authorities to guarantee food safety for all. Therefore, intensive efforts are being made to establish minimal disease-eliciting doses of gluten and consequently to improve gluten-free labeling. These efforts depend to a high degree on the availability of methods capable of detecting the protein in food samples at levels as low as possible. Current analytical approaches rely on the use of antibodies as selective recognition elements. With limited sensitivity, these methods exhibit some deficiencies that compromise the accuracy of the obtained results. Aptamers provide an ideal alternative for designing biosensors for fast and selective measurement of gluten in foods. This article highlights the challenges in gluten detection, the current status of the use of aptamers for solving this problem, and what remains to be done to move these systems into commercial applications.Entities:
Keywords: aptamers; biosensors; celiac disease; gliadin; gluten; prolamins
Mesh:
Substances:
Year: 2016 PMID: 27104578 PMCID: PMC4931476 DOI: 10.3390/bios6020016
Source DB: PubMed Journal: Biosensors (Basel) ISSN: 2079-6374
Figure 1Schematic of the main steps and challenges associated with gluten determination in food samples.
Commercial enzyme-linked immunosorbent assays for gluten detection in food.
| Antibody | Manufacturer | Commercial Name | Format | L.D. (ppm gluten) |
|---|---|---|---|---|
| Skerrit [ | Neogen | Biokits | Sandwich | 1 |
| BioCheck | Gluten Check | Sandwich | 5 | |
| ELISA technologies | EZ-Gluten | Lateral flow device | 10 | |
| R5 [ | Bio Control Systems | TransiaPlateProlamins | Sandwich | 3 |
| Neogen | Veratox | Sandwich | 5 | |
| R-Biopharm | RidaScreen | Sandwich | 5 | |
| RidaScreenGliadincompetitive | Competitive | 5 | ||
| Rida Quick | Lateral flow device | 5 | ||
| Ingenasa | Ingezim gluten | Sandwich | 3 | |
| G12 [ | Biomedal | Gluten Tox | Sandwich | 0.6 |
| Gluten Tox | Competitive | 3 | ||
| Gluten Tox | Lateral flow device | 3 | ||
| RomerLab | Agra Quant | Sandwich | 2 | |
| Agra-Strip | Lateral flow device | 5 |
Figure 2(A) Alignment of anti-gliadin G33 and anti-peptide Gli1 aptamers. The 12-nt motif is marked in yellow. (B) Global alignments of anti-gliadin G33 and anti-peptides aptamers. The homologous regions are marked in yellow.
Figure 3Schematic of the different methods used for evaluating the aptamer binding affinity and comparison of the binding constants obtained for the interaction between aptamers and 33-mer peptide or PWG. Constants evaluated by (A) isothermal titration calorimetry (ITC); (B) surface plasmon resonance spectroscopy (SPR); (C) ICP-MS; (D) faradaic impedance spectroscopy (FIS); (E) chronoamperometry; and (F) fluorescence.
Figure 4Aptamer-based assays for gliadin determination in processed foods.